Literature DB >> 12967771

The distinct role of mGlu1 receptors in post-ischemic neuronal death.

Domenico E Pellegrini-Giampietro1.   

Abstract

Metabotropic glutamate receptors of the mGlu(1) and mGlu(5) subtypes exhibit a high degree of sequence homology and are both coupled to phospholipase C and intracellular Ca(2+) mobilization. However, functional differences have been detected for these receptor subtypes when they are coexpressed in the same neuronal populations. Experimental evidence indicates that mGlu(1) and mGlu(5) receptors play a differential role in models of cerebral ischemia and that only mGlu(1) receptors are implicated in the pathways leading to post-ischemic neuronal injury. The localization of mGlu(1) receptors in GABA-containing interneurons rather than in hippocampal CA1 pyramidal cells that are vulnerable to ischemia has prompted studies that have provided a new viewpoint on the neuroprotective mechanism of mGlu(1) receptor antagonists. The hypothesis predicts that these pharmacological agents attenuate post-ischemic injury by enhancing GABA-mediated neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967771     DOI: 10.1016/S0165-6147(03)00231-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  23 in total

1.  Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents.

Authors:  Carol D Farr; Philip R Gafken; Angela D Norbeck; Catalin E Doneanu; Martha D Stapels; Douglas F Barofsky; Manabu Minami; Julie A Saugstad
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

2.  Hypobaric Preconditioning Modifies Group I mGluRs Signaling in Brain Cortex.

Authors:  Dmitry G Semenov; Alexandr V Belyakov; Tatjana S Glushchenko; Mikhail O Samoilov; Elzbieta Salinska; Jerzy W Lazarewicz
Journal:  Neurochem Res       Date:  2015-08-29       Impact factor: 3.996

Review 3.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

4.  Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation.

Authors:  Miou Zhou; Wei Xu; Guanghong Liao; Xiaoning Bi; Michel Baudry
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

5.  Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function.

Authors:  G Nagesh Babu; Alok Kumar; Ram Lakhan Singh
Journal:  Neurotox Res       Date:  2010-03-09       Impact factor: 3.911

6.  Effect of glutamate on inflammatory responses of intestine and brain after focal cerebral ischemia.

Authors:  Lei Xu; Jie Sun; Ran Lu; Qing Ji; Jian-Guo Xu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

7.  Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture.

Authors:  Fang Liu; Tucker A Patterson; Natalya Sadovova; Xuan Zhang; Shuliang Liu; Xiaoju Zou; Joseph P Hanig; Merle G Paule; William Slikker; Cheng Wang
Journal:  Toxicol Sci       Date:  2012-10-11       Impact factor: 4.849

8.  Modes of Neuronal Calcium Entry and Homeostasis following Cerebral Ischemia.

Authors:  J L Cross; B P Meloni; A J Bakker; S Lee; N W Knuckey
Journal:  Stroke Res Treat       Date:  2010-11-01

9.  Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.

Authors:  E Luccini; V Musante; E Neri; M Brambilla Bas; P Severi; M Raiteri; A Pittaluga
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 10.  Metabotropic glutamate receptors: from the workbench to the bedside.

Authors:  F Nicoletti; J Bockaert; G L Collingridge; P J Conn; F Ferraguti; D D Schoepp; J T Wroblewski; J P Pin
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.